bioAffinity Technologies, Inc. SEC filings BIAF

bioAffinity Technologies, Inc. has 399 filings in SEC EDGAR's recent list, going back to Jul 26, 2017. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 16, 2026 Dec 31, 2025
10-K Annual report Mar 16, 2026 Dec 31, 2025
ARS Annual report to shareholders Jun 2, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 15, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
BIAF (Nasdaq), BIAFW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Antonio, TX
SEC filer status
, Emerging growth company
SEC CIK
1712762
Former names
bioAffinity Technologies, Inc. (until Nov 3, 2026)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.